MAPK3 and malignant colon neoplasm: Kim et al. (24) reported that AMPK may inhibit the MAPK3/1 pathway; the inhibition of AMPK by expressing a dominant-negative form potentiates MAPK3/1 activation under glucose deprivation in colon cancer cells.